Lipid lowering and Alzheimer disease risk: A mendelian randomization study

OBJECTIVE: To examine whether genetic variation affecting the expression or function of lipid‐lowering drug targets is associated with Alzheimer disease (AD) risk, to evaluate the potential impact of long‐term exposure to corresponding therapeutics. METHODS: We conducted Mendelian randomization anal...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Neurol
Asıl Yazarlar: Williams, Dylan M., Finan, Chris, Schmidt, Amand F., Burgess, Stephen, Hingorani, Aroon D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2019
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944510/
https://ncbi.nlm.nih.gov/pubmed/31714636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25642
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller